期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Effect of Ca addition on solidification microstructure of hypoeutectic Al-Si casting alloys 被引量:1
1
作者 Xiang-yi Jiao chao-feng liu +5 位作者 Jun Wang Zhi-peng Guo Jun-you Wang Zhuo-ming Wang Jun-ming Gao Shou-mei Xiong 《China Foundry》 SCIE 2019年第3期153-160,共8页
The effect of Ca addition on the solidification microstructure of hypoeutectic Al-Si casting alloys was investigated using scanning electron microscopy (SEM) and differential scanning calorimetry (DSC) methods with pa... The effect of Ca addition on the solidification microstructure of hypoeutectic Al-Si casting alloys was investigated using scanning electron microscopy (SEM) and differential scanning calorimetry (DSC) methods with particular attention focused on the change of morphologies of primary α-Al and eutectic silicon. Meanwhile,solute distribution in solid-liquid was simulated according to Scheil-Gulliver law. Results showed that primary α-Al and eutectic silicon were refined as Ca content increased because of the variation of the solute concentration in liquid. The addition of Ca increased the nucleation sites like Al3Ti or Al2Cu to promote the nucleation of primary α-Al. Affected by modification effect of Ca, the shape of eutectic silicon changed from flake to fibrous structure. In addition, coarse plate Ca-rich phases could be found along the grain boundary with high Ca content. 展开更多
关键词 Ca ADDITION PRIMARY α-Al EUTECTIC silicon REFINEMENT
下载PDF
依那普利抑制同型半胱氨酸致血管内皮损伤的保护作用 被引量:1
2
作者 周岩芬 蒋伟 +7 位作者 张敏 赵连友 侯杰军 陈金锋 范虹 于小勇 刘超峰 雷忠义 《心脏杂志》 CAS 2019年第4期388-391,402,共5页
目的探讨依那普利对同型半胱氨酸(Hcy)引起的血管内皮细胞损伤的保护作用。方法取大鼠主动脉内皮细胞,培养并传代备用,进行血管内皮细胞药物保护实验。分为正常对照组(正常组):不加Hcy及依那普利;损伤组:给予Hcy 2000 μmol/L;干预组:... 目的探讨依那普利对同型半胱氨酸(Hcy)引起的血管内皮细胞损伤的保护作用。方法取大鼠主动脉内皮细胞,培养并传代备用,进行血管内皮细胞药物保护实验。分为正常对照组(正常组):不加Hcy及依那普利;损伤组:给予Hcy 2000 μmol/L;干预组:在给予Hcy 2000 μmol/L的同时再给予依那普利,依那普利的浓度不同又分为干预A、B、C、D和E组,其依那普利的浓度依次为10,20,40,80和160 nmol/L。内皮细胞的鉴定利用因子VIII间接免疫荧光;利用光学仪器进行血管内皮细胞形态学观察;测定各组细胞乳酸脱氢酶(LDH)的活性;利用CCK8试剂检测各组血管内皮细胞活力;利用细胞计数板测定活细胞百分率。结果:① Hcy损伤组血管内皮细胞呈现出细胞损伤形态学改变;②各组细胞LDH活性与正常对照组(100%)比较分别为:损伤组细胞LDH活性为(157 ± 17)%,干预C组(依那普利浓度40 nmol/L)细胞活性为(126 ± 7)%。干预C组较损伤组LDH活性显组降低(P<0.01);③血管内皮细胞活力:正常组细胞活力定为 100%,损伤组为(52 ± 6)%,干预C组为(75 ± 6)%。干预C组细胞活力较损伤组相比细胞活力显著升高(P<0.01);④活细胞百分率测定,与正常对照组[(98 ± 1)%]比较,损伤组活细胞比例[(72 ± 4)%]显著降低(P<0.01);干预C组活细胞比例为(87 ± 3)%较损伤组显著增加(P<0.01)。结论依那普利可改善Hcy对血管内皮细胞的损伤,具有保护作用。 展开更多
关键词 依那普利 同型半胱氨酸血症 血管内皮细胞
下载PDF
Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection:a randomized trial 被引量:3
3
作者 Jun liu Dan-Dan Li +77 位作者 Wei Dong Yu-Qi liu Yang Wu Da-Xuan Tang Fu-Chun Zhang Meng Qiu Qi Hua Jing-Yu He Jun Li Bai Du Ting-Hai Du Lin-Lin Niu Xue-Jun Jiang Bo Cui Jiang-Bin Chen Yang-Gan Wang Hai-Rong Wang Qin Yu Jing He Yi-Lin Mao Xiao-Fang Bin Yue Deng Yu-Dan Tian Qing-Hua Han Da-Jin liu Li-Qin Duan Ming-Jun Zhao Cui-Ying Zhang Hai-Ying Dai Ze-Hua Li Ying Xiao You-Zhi Hu Xiao-Yu Huang Kun Xing Xin Jiang chao-feng liu Jing An Feng-Chun Li Tao Tao Jin-Fa Jiang Ying Yang Yao-Rong Dong Lei Zhang Guang Fu Ying Li Shu-Wei Huang Li-Ping Dou Lan-Jun Sun Ying-Qiang Zhao Jie Li Yun Xia Jun liu Fan liu Wen-Jin He Ying Li Jian-Cong Tan Yang Lin Ya-Bin Zhou Jian-Fei Yang Guo-Qing Ma Hui-Jun Chen He-Ping liu Zong-Wu liu Jian-Xiong liu Xiao-Jia Luo Xiao-Hong Bin Ya-Nan Yu Hai-Xia Dang Bing Li Fei Teng Wang-Min Qiao Xiao-Long Zhu Bing-Wei Chen Qi-Guang Chen Chun-Ti Shen Yong-Yan Wang Yun-Dai Chen Zhong Wang 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2021年第10期3009-3018,共10页
It's a challenge for detecting the therapeutic targets of a polypharmacological drug from variations in the responsed networks in thedfferentiated populations with complex diseases,as stable coronary heart disease... It's a challenge for detecting the therapeutic targets of a polypharmacological drug from variations in the responsed networks in thedfferentiated populations with complex diseases,as stable coronary heart disease.Here,in an adaptive,31-center,randomized,double-blind trial invoving 920 patients with moderate symptomatic stable angina treated by 14-day Danhong injection(DHI),a kind of polyphamacological drug with high quality control,or placebo(0.9%saline),with 76-day following-up,we firstly confrmed that DHl couldincrease the proportion of patients with clinically significant changes on angina-frequency assessed by Seattle Angina Questionnaire(ASAQ-AF220)(12.78%at Day 30,95%confidence interval[C]5.86-19.71%,P=0.0003,13.82%at Day 6C0,95%CI 6.82-20.82%,P=0.0001and 8.95%at Day 90,95%CI 2.06-15.85%,P=0.01).We also found that there were no significant differences in new-onset major vascularevents(P=0.8502)and serious adverse events(P=0.9105)between DHl and placebo.After performing the RNA sequencing in 62 selectedpatients,we developed a systemic modular approach tp identfy differentilly expressed modules(DEMs)of DHI with the Z_(summay)valueless than 0 compared with the control group,calculated by weighted gene co-expression network analysis(WGCNA),and sketched out thebasic framework on a modular map with 25 functional modules targeted by DII.Furthermore,the effective therapeutic module(ETM),defined as the highest corelation value with the phenotype alteration(SAQ-AF,the change in SAQ-AF at Day 30 from baseline)calculatedby WGCNA,was identifed in the population with the best effect(ASAQ-AF240),which is related to anticoagulation and regulation ofcholesterol metabolism.We assessed the modular flexbility of this ETM using the global topological D value based on Euclidean distance,which is corelated with phenotype alteration(r^(2):0.8204,P=0.019)by linear regression.Our study identified the ant-angina therapeuticmodule in the effective population treated by the multi-target drug.Modular methods facilitate the discovery of network pharmacologicalmechanisms and the advancement of precision medicine.(ClinicalTrials.gov identifier:NCTO1681316). 展开更多
关键词 ANGINA injection SKETCH
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部